Search research articles
Contact Us
Filters
Showing results (1071-1080 of 1,104) with videos related to
Page
of 111
Sort By:
American Journal of Hematology
|
October 19, 2012
Fludarabine, cytarabine, and attenuated-dose idarubicin (m-FLAI) combination therapy for elderly acute myeloid leukemia patients
Inho Kim, Youngil Koh, Sung-Soo Yoon, et al.
The New England Journal of Medicine
|
August 14, 2020
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
Courtney D DiNardo, Brian A Jonas, Vinod Pullarkat, et al.
Cancer Research and Treatment
|
January 3, 2023
Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404)
Hyungwoo Cho, Dok Hyun Yoon, Dong-Yeop Shin, et al.
International Journal of Hematology
|
September 5, 2020
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone
Ho Sup Lee, Kihyun Kim, Je-Jung Lee, et al.
The Lancet. Haematology
|
July 30, 2023
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study
Aaron T Gerds, Srdan Verstovsek, Alessandro M Vannucchi, et al.
Science (New York, N.Y.)
|
May 21, 2005
Patient-specific embryonic stem cells derived from human SCNT blastocysts
Woo Suk Hwang, Sung Il Roh, Byeong Chun Lee, et al.
Blood
|
June 30, 2026
TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis
Naveen Pemmaraju, Adam J Mead, Tim C P Somervaille, et al.
Annals of Hematology
|
December 25, 2019
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study)
Jae-Cheol Jo, Ho Sup Lee, Kihyun Kim, et al.
The New England Journal of Medicine
|
October 31, 2019
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i>-Mutated AML
Alexander E Perl, Giovanni Martinelli, Jorge E Cortes, et al.
Annals of Hematology
|
May 22, 2026
Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia
Seok Lee, Hyeoung-Joon Kim, June-Won Cheong, et al.
Page
of 111
Search research articles
Search
Showing results (1071-1080 of 1,104) with videos related to
Sort By:
Page
of 111
American Journal of Hematology
|
October 19, 2012
Fludarabine, cytarabine, and attenuated-dose idarubicin (m-FLAI) combination therapy for elderly acute myeloid leukemia patients
Inho Kim, Youngil Koh, Sung-Soo Yoon, et al.
The New England Journal of Medicine
|
August 14, 2020
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
Courtney D DiNardo, Brian A Jonas, Vinod Pullarkat, et al.
Cancer Research and Treatment
|
January 3, 2023
Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404)
Hyungwoo Cho, Dok Hyun Yoon, Dong-Yeop Shin, et al.
International Journal of Hematology
|
September 5, 2020
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone
Ho Sup Lee, Kihyun Kim, Je-Jung Lee, et al.
The Lancet. Haematology
|
July 30, 2023
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study
Aaron T Gerds, Srdan Verstovsek, Alessandro M Vannucchi, et al.
Science (New York, N.Y.)
|
May 21, 2005
Patient-specific embryonic stem cells derived from human SCNT blastocysts
Woo Suk Hwang, Sung Il Roh, Byeong Chun Lee, et al.
Blood
|
June 30, 2026
TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis
Naveen Pemmaraju, Adam J Mead, Tim C P Somervaille, et al.
Annals of Hematology
|
December 25, 2019
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study)
Jae-Cheol Jo, Ho Sup Lee, Kihyun Kim, et al.
The New England Journal of Medicine
|
October 31, 2019
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i>-Mutated AML
Alexander E Perl, Giovanni Martinelli, Jorge E Cortes, et al.
Annals of Hematology
|
May 22, 2026
Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia
Seok Lee, Hyeoung-Joon Kim, June-Won Cheong, et al.
Page
of 111